Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Recruiting3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed240%
recruiting360%

Recent Activity

3 active trials
Showing 5 of 5
recruiting

AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis

NCT06709209
recruiting

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease

NCT06505304
recruiting

Epigenetic Regulation of Colorectal Polyps and Cancer

NCT06206603
completed

INF-α Innate Immune Response to Gliadin

NCT03221647
completednot_applicable

Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease

NCT00780949

Clinical Trials (5)

Showing 5 of 5 trials
NCT06709209

AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis

Recruiting
NCT06505304

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease

Recruiting
NCT06206603

Epigenetic Regulation of Colorectal Polyps and Cancer

Recruiting
NCT03221647

INF-α Innate Immune Response to Gliadin

Completed
NCT00780949Not Applicable

Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5